Frequently Asked Questions

Fasting depends on the type of scan and whether contrast is required. Some MRI, CT and ultrasound studies require fasting, while others do not. Our patient support team will give you clear, scan-specific instructions.

Comfortable clothing is best. For MRI, please avoid clothing with metal zips, buttons or underwire. If needed, appropriate attire can be provided on the day. Our staff will ask safety questions prior to your MRI scan.

Claustrophobia and scan anxiety are common concerns and our team is experienced in supporting patients through their examination comfortably. Please let us know when booking so we can take extra care to prepare you for your visit. Our in-scanner audio-visual platform allows you to watch a movie or your favourite TV show throughout your examination, which many patients find significantly reduces anxiety. For patients with more significant claustrophobia, GP-prescribed mild oral sedation may be appropriate — please speak with your GP prior to your appointment and note that a support person will be required to accompany you home if sedation is taken.

Scan times vary depending on the type of imaging. CT scans typically take around 5–10 minutes. MRI scans take 30–45 minutes for most standard studies, while a comprehensive Whole Body MRI™ can take up to 100 minutes. DEXA scans take around 10 minutes. X-rays typically take around 5 minutes. Ultrasound typically takes around 30 minutes. Our patient support team will confirm the expected duration when scheduling your scan.

Most reports are available within 48 to 72 hours and sent directly to your referring doctor. Clinically urgent scans are prioritised for reporting. Some complex or subspecialty studies, such as Whole Body MRI ™ or cardiac studies, may take longer — please allow up to 5 to 7 business days for more detailed examinations. Some scans may be eligible for elective expedited reporting for a small fee, please speak to our team before or after your scan to learn more. Your report and images will also be accessible through the MBR Health patient portal once finalised. If you require your results sooner, please let our team know at the time of booking and we will do our best to accommodate your request.

Yes. Your images are available in the patient app as soon as your referring doctor receives the results. You can view and download them directly from the app, and our patient support team can also assist if you need help.

Maybe — many MRI scans can be performed without contrast. Our research-grade 3T MRI is highly sensitive, which often means less or even no contrast is needed. Contrast is used when it will provide meaningful additional diagnostic information. The decision is based on your referral, clinical details and imaging findings. If contrast is recommended, we carefully assess safety, kidney function and clinical need to ensure the best outcome for you.

Fasting depends on whether contrast is required. We recommend fasting for 2 hours before any CT that requires contrast. Our patient support team will give you clear, scan-specific instructions.

Comfortable clothing is best. For MRI, please avoid clothing with metal zips, buttons or underwire. Our staff will ask safety questions prior to your MRI scan.

Fasting depends on whether contrast is required. We recommend fasting for 2 hours before any CT that requires contrast. Our patient support team will give you clear, scan-specific instructions.

Comfortable clothing is best. For CT, please avoid clothing with metal zips, buttons or underwire in the field of view. If needed, appropriate attire can be provided on the day.

Fasting depends on the type of ultrasound. Typically fasting will be required for scans of the abdomen, pelvis and some of the ultrasound dopplers. Our patient support team will give you clear, scan-specific instructions.

Comfortable clothing is best that allows easy access to the area of interest by the sonographer.

Maybe — many MRI scans can be performed without contrast. Our research-grade 3T MRI is highly sensitive, which often means less or even no contrast is needed. Contrast is used when it will provide meaningful additional diagnostic information – typically for diagnostic oncological, nerve or vessel imaging contrast is required. The decision is based on your referral, clinical details and imaging findings. If contrast is recommended, we carefully assess safety, kidney function and clinical need to ensure the best outcome for you.

Maybe — many CT scans can be performed without contrast however CT imaging assessing oncology, or vessels (including for pulmonary or cardiac) will require contrast. The decision is based on your referral, clinical details and imaging findings. If contrast is recommended, we carefully assess safety, kidney function and clinical need to ensure the best outcome for you.

At MBR Health, every scan is radiologist-led and personalised, not a one-size-fits-all approach. We pair some of Australia’s most advanced medical imaging, including our research-grade 3T MRI and Spectral CT, with cutting-edge regenerative and cellular therapies, customising imaging sequences to your clinical needs, anatomy and personal health history. Our focus is on precision, clarity and actionable insights, enabling proactive preventive care rather than reactive treatment, and supporting confident clinical decision-making.

All scans at MBR Health are carefully reviewed and reported by our specialist radiologists, with expertise specifically matched to the type of study being performed. We do not rely on AI-only reporting — every scan receives expert, personalised interpretation, ensuring the highest level of diagnostic accuracy and providing actionable insights for your healthcare team.

MBR Health is a clinician-led, family owned medical imaging and precision health group founded by Dr Zane Sherif, Specialist Radiologist. The practice has been developed around a simple principle: imaging should not be treated as a generic commodity, but as a critical diagnostic step that can shape prevention, treatment planning and long-term health decisions. Based on the Gold Coast, MBR Health brings together advanced diagnostic imaging, specialist radiology oversight and selected image-guided therapies within a personalised clinical framework.

MBR Health is designed around precision, personalisation and diagnostic depth. Rather than applying a one-size-fits-all scanning approach, our imaging is radiologist-led and tailored to the clinical question, the patient’s anatomy, prior imaging and health history. Our services include advanced medical imaging such as 3T MRI, Spectral CT, ultrasound, X-ray and dental imaging, alongside selected regenerative and image-guided therapies where clinically appropriate. The focus is not simply on producing images, but on delivering clear, clinically useful information that supports confident decision-making.

Your scan is reviewed and reported by a specialist radiologist. At MBR Health, imaging is interpreted by doctors with expertise matched to the type of study being performed, whether that involves musculoskeletal imaging, oncology, neurological imaging, dental imaging, CT, MRI, ultrasound or X-ray. We do not use AI-only reporting. Every report is prepared with specialist medical oversight, helping ensure your referring doctor receives clinically meaningful information to guide the next step in your care.

MBR Health (previously Mermaid Beach Radiology) is located at 2469 Gold Coast Highway, Mermaid Beach QLD — on the corner of Ocean Street and the Gold Coast Highway. Free on-site parking is available at the rear of the building, accessed via 46 Ocean Street. Our clinic is easily accessible by public transport along the Gold Coast Highway corridor. Please contact our friendly team for specific directions or any questions about finding us.

In most cases, yes. A referral from your GP or specialist is required for all MRI, CT, ultrasound, X-Ray and diagnostic procedure appointments at MBR Health. A referral ensures the correct examination is performed for your clinical needs and allows your results to be communicated directly to your treating clinician. Some services do not require a referral — including DEXA body composition or MRI Brain or Liver Quantification studies. Please contact our friendly bookings team if you are unsure whether a referral is required for your specific examination and we will be happy to assist.

Yes — your referral is yours to take anywhere. If you have been referred for imaging by your GP or specialist, you are not required to attend the facility named or printed on your referral. You are free to choose where your imaging is performed and are welcome to bring your referral to MBR Health regardless of which practice, hospital or imaging provider is named on the referral form. We accept referrals in all formats including handwritten, printed and electronic referrals from all registered medical practitioners. If you have any questions about your referral or would like to book an appointment, please contact our friendly bookings team who will be happy to assist.

MBR Health is a mixed billing clinic. Medicare coverage depends on the type of examination, your individual eligibility and the clinical indication for your scan. Some scans and procedures — such as advanced Spectral CT imaging or regenerative medicine procedures — use specialised technology that goes beyond standard Medicare rebate inclusions.

* Spectral CT and X-ray — many diagnostic examinations are bulk billed for eligible Medicare cardholders with a valid referral.
* Ultrasound — a Medicare rebate applies for eligible examinations with an out-of-pocket fee payable
* MRI — Privately billed. To understand why MRI at MBR Health is privately billed, please read our article: Understanding MRI and Medicare Rebates.

Our team will always confirm your out-of-pocket costs clearly before your appointment. Please contact our bookings team to discuss the costs associated with your specific examination prior to booking.

Some scans may be bulk billed when Medicare criteria are met. However, MRI, advanced Spectral CT and regenerative medicine procedures use specialised technology and protocols that go beyond standard rebate models. Our priority is diagnostic accuracy and minimising repeat imaging. Any rebates and out-of-pocket costs are discussed with you before your appointment.

Yes. MBR Health offers the Executive Preventive Health Program for organisations looking to provide executive health screening for their leadership teams. The program uses precision, multi-modality whole-body imaging to screen for cancer, cardiac, metabolic, neurological and musculoskeletal conditions within a single, integrated pathway. Tailored group offerings are available for organisations. Please enquire directly to discuss your team’s requirements.

The best scan for back pain depends on what we’re trying to find. A 3T MRI gives detailed information about discs, nerves and soft tissues. CT, or Spectral CT, is more useful when we need a closer look at the bones, joints or changes from injury or surgery.

MBR Health provides advanced spine imaging on the Gold Coast for back pain, neck pain, sciatica, disc-related conditions and post-surgical symptoms. Imaging is tailored to the clinical question and may include 3T MRI, Spectral CT or other targeted approaches.

Yes. Advanced MRI can identify nerve irritation, disc-related changes and areas where nerves may be under pressure. These findings can help explain symptoms such as sciatica, radiating pain, numbness, tingling or weakness.

Back pain radiating down the leg may be caused by nerve irritation or compression, often from disc herniation, foraminal narrowing, spinal stenosis or other causes of lumbar radiculopathy.

Spinal stenosis means narrowing of the spinal canal or the spaces where nerves travel. This can contribute to back pain, leg heaviness, burning, numbness, or reduced walking tolerance. Imaging helps show where the narrowing is occurring and how severe it may be.

A disc bulge is a broader extension of disc material beyond the normal disc margin. A disc herniation is a more focal protrusion or extrusion of disc material and may be more likely to irritate or compress a nearby nerve. The clinical significance depends on the location, size and whether symptoms match the imaging.

Yes. CT can show bony detail very well and may help assess facet joint arthritis, bony stenosis, calcified disc material, and post-surgical anatomy. MRI and CT answer different questions, so the best test depends on the structure being assessed.

Imaging may be considered when pain is persistent, recurrent, associated with arm or leg symptoms, follows injury, fails to improve with conservative care, or when the symptom pattern suggests nerve compression or a more specific structural cause. The decision should be guided by the clinical question rather than imaging for its own sake.

MRI can help assess post-surgical changes, including scar tissue, recurrent disc disease, residual narrowing, or other structural causes of ongoing symptoms. In some cases, CT may also be useful, especially where hardware or bony anatomy need closer review.

Radiculopathy refers to symptoms caused by irritation or compression of a spinal nerve root. It may cause pain, tingling, numbness, weakness, or altered sensation radiating into the arm or leg.

This page focuses on diagnosis-led assessment of back pain and spine injury. Where imaging identifies a treatable pain generator, patients may then explore image-guided treatment options through our Regenerative & Targeted Therapies pathways.

MBR Health provides specialist CT-guided spinal procedures on the Gold Coast within an advanced radiology environment, allowing diagnostic imaging, procedural planning and precision treatment to remain connected.

Osteoarthritis is common in Australia. Arthritis Australia states that 1 in 5 Australians over the age of 45 have osteoarthritis, and AIHW reports that prevalence rises sharply from age 45 onward.

The best scan depends on the clinical question. A 3T MRI is often useful for cartilage, synovium, tendons, ligaments, marrow and soft tissues. CT or Spectral CT can be useful when bone, calcification, alignment or post-surgical structure needs closer assessment.

MBR Health provides advanced joint imaging on the Gold Coast for osteoarthritis, cartilage injury, tendon pain, swelling, post-surgical symptoms and persistent joint pain.

Yes. MRI can show cartilage loss, subchondral bone change, synovitis, marrow oedema, tendon pathology and other joint findings relevant to osteoarthritis and persistent joint pain.

Osteoarthritis is primarily a degenerative joint process involving cartilage wear and structural change. Inflammatory arthritis involves immune-driven synovial inflammation and may be associated with swelling, systemic symptoms and multi-joint involvement.

Yes. Tendinopathy and bursitis can mimic joint pain and may coexist with osteoarthritis or cartilage pathology.

Subchondral bone oedema refers to stress-related or reactive change in the bone beneath the cartilage surface. It can be associated with pain, overload and osteoarthritis progression.

Imaging may be considered when joint pain is persistent, recurrent, associated with swelling or mechanical symptoms, following injury or surgery, or when a more targeted treatment pathway is being considered.

Yes. MRI can often show cartilage thinning, focal defects, associated marrow change, and surrounding soft-tissue abnormalities that may contribute to symptoms.

Yes. CT can show bony change, osteophytes, calcification, alignment issues, and subchondral structural change very well. MRI and CT answer different questions, so the most useful test depends on the structure being assessed.

This page focuses on diagnosis-led assessment of joint pain and osteoarthritis. Where imaging identifies a treatable structural source, patients may then explore image-guided treatment options through the Regenerative & Targeted Therapies pathways.

The best scan depends on the clinical question. A 3T MRI is often most useful for tendon tears, ligament integrity, surrounding soft tissues and post-surgical review. Ultrasound can be useful for superficial tendons, dynamic assessment and procedural guidance. CT or Spectral CT may help when bone, avulsion injury, calcification or post-surgical hardware need closer assessment.

MBR Health provides advanced tendon and ligament imaging on the Gold Coast for tendon tears, ligament injury, tendinopathy, ACL-related concerns, insertional pain and post-surgical soft-tissue assessment.

Yes. MRI can often show tendon degeneration, partial tears, full-thickness tears, surrounding inflammation, and associated structural abnormalities.

Yes. MRI can assess ligament sprain, partial tearing, complete rupture and associated bone or soft-tissue injury.

Tendinopathy refers to a degenerative or structurally abnormal tendon state often associated with pain, thickening, impaired load tolerance, and chronic overuse.

Yes, while these treatments are still evolving, there are now several publications demonstrating full non-surgical healing of ACL using PRP. Please refer to our publication here.

Yes, while these treatments are still evolving, there are now several publications demonstrating full non-surgical healing of tendons using PRP. Please refer to our publication here.

Enthesopathy refers to pathology at the point where a tendon or ligament attaches to bone. It may involve microtears, stress change, inflammation, or calcification.

Imaging may be considered when pain or instability persists, when symptoms recur despite rehabilitation, when surgery is being considered or avoided, or when the structural diagnosis is still unclear.

This page focuses on diagnosis-led assessment of tendon and ligament injury. Where imaging identifies a treatable structural source, patients may then explore image-guided treatment options through the Regenerative & Targeted Therapies pathways.

The best scan depends on the clinical question. NerveView MRI and 3T MRI are often the most useful tools for nerve pain, radiculopathy, focal neuritis and structural correlation of neuropathic symptoms. Ultrasound can help in selected superficial nerve problems.

MBR Health provides advanced nerve pain imaging on the Gold Coast for sciatica, pinched nerves, radiculopathy, nerve entrapment and unexplained neuropathic symptoms.

NerveView MRI is an advanced MRI technique designed to better show nerve inflammation, focal neuritis and selected nerve-related abnormalities that may not be obvious on routine imaging alone.

Yes. MRI can often show disc herniation, foraminal narrowing, spinal stenosis or other structural causes of nerve compression. Advanced techniques may also help assess nerve inflammation.

Radiculopathy refers to symptoms caused by irritation or compression of a spinal nerve root. It may produce radiating pain, numbness, tingling, weakness, or altered sensation in the arm or leg.

Yes. Some nerve pain arises from a spinal nerve root, while other symptoms come from entrapment or irritation further along the nerve course. The imaging pathway needs to match the likely level of the problem.

Imaging may be considered when symptoms persist, recur, radiate, include sensory change or weakness, following surgery, or when the structural source of the nerve pain remains unclear.

Head and facial pain can come from several overlapping systems, including the teeth, jaw joints, sinuses, facial nerves, cervical spine, muscles, blood vessels or previous surgery. Because different causes can feel very similar, accurate diagnosis often requires looking beyond the site of pain. At MBR Health, imaging is tailored to the suspected source — whether that involves the brain, trigeminal nerve, TMJ, sinuses, neck or facial structures.

Yes. Upper cervical spine problems can refer pain into the head, face, jaw, temple or behind the eye. This can occur when joints, discs, ligaments or nerves in the upper neck irritate pain pathways that overlap with facial sensation. In selected cases, high-resolution MRI of the cervical spine or cranio-cervical junction may help identify structural causes that are not visible on routine assessment.

The best imaging depends on the suspected cause. MRI is often preferred for nerves, brain, soft tissues, TMJ and skull base assessment. CT may be useful for bone, sinus disease, dental structures, prior surgical change or complex anatomy. At MBR Health, facial pain imaging is not approached as a single generic scan. The protocol is planned around the pain pattern, clinical history and suspected anatomical pathway.

MRI may help assess causes of trigeminal neuralgia or trigeminal neuropathy, including vascular contact, nerve compression, inflammation, tumour, demyelination or post-surgical change. A routine brain MRI may not always be enough. In many cases, dedicated high-resolution imaging through the trigeminal nerve, skull base and posterior fossa is needed to properly assess the nerve pathway.

Yes. Dental infection, cracked teeth, impacted wisdom teeth, jaw alignment problems and temporomandibular joint dysfunction can all contribute to facial pain. However, not all facial pain is dental. Trigeminal neuralgia, sinus disease, nerve irritation, cervical referral and post-treatment pain can mimic tooth or jaw pain. Dental imaging, OPG, CT or MRI may be used depending on the clinical question.

A normal dental X-ray does not exclude nerve-related, jaw joint, sinus, skull base or cervical spine causes of pain. Some facial pain arises from structures outside the teeth, even when the pain feels dental. This is why persistent or unexplained facial pain may require broader imaging, such as MRI of the trigeminal nerve, TMJ imaging, sinus CT or cervical spine MRI.

Imaging may be considered when pain is persistent, severe, one-sided, nerve-like, associated with numbness, triggered by touch or chewing, linked to previous surgery, or not explained by dental or clinical examination. At MBR Health, imaging is used to help identify whether pain is structural, inflammatory, neurological, dental, sinus-related or referred from another region.

Pain after surgery can persist for many reasons. These may include scar tissue, nerve irritation, neuroma formation, joint overload, altered biomechanics, inflammation, infection, hardware-related issues or incomplete resolution of the original problem. Persistent post-surgical pain should not automatically be dismissed as “normal healing.” In selected cases, targeted imaging can help determine whether there is a visible structural or nerve-related cause.

Chronic post-surgical pain is pain that continues beyond the expected healing period after an operation. It may be sharp, burning, aching, pulling, electric, hypersensitive or triggered by movement, pressure or scar contact. It is often more complex than simple tissue injury. Nerve irritation, scar tethering and altered pain processing can all contribute.

MRI can be very useful after surgery, particularly for assessing soft tissues, nerves, muscles, joints, discs, tendons, inflammation, fluid collections and recurrent or residual pathology. However, post-surgical MRI needs careful protocol planning. Metal artefact, scar tissue and altered anatomy can make interpretation difficult unless the scan is tailored to the operation and clinical question.

Yes. Scar tissue can sometimes become painful if it tethers tissue, restricts movement, irritates nearby nerves or forms part of a painful scar or neuroma pattern. Imaging may help assess the deeper tissues beneath a scar, particularly when pain is focal, reproducible, worsening, associated with altered sensation or linked to a specific movement.

Sometimes. Larger nerves, neuromas, nerve swelling, entrapment, scarring around nerves or denervation changes in muscles may be visible on advanced MRI or high-resolution ultrasound. Not all nerve pain is visible on imaging, but a targeted study can help identify anatomical causes and guide whether further nerve assessment, diagnostic injection or specialist review is appropriate.

The best imaging depends on the operation and the suspected pain generator. MRI is often preferred for soft tissue, nerve, joint, spine and muscle assessment. CT may be better for bone, hardware, fusion, fractures or complex surgical anatomy. Ultrasound may help assess superficial tendons, scars, collections and some peripheral nerves. At MBR Health, post-surgical imaging is planned around the operation performed, the patient’s symptoms and the structures most likely to be responsible.

Yes. Imaging can help determine whether pain is more likely to be coming from a joint, nerve, tendon, scar, implant, bone, disc or soft-tissue structure. In some cases, imaging may also guide targeted diagnostic injections or procedures, helping confirm the pain source before considering further treatment. This is particularly important when symptoms persist despite surgery or when the diagnosis remains unclear.

Post-surgical pain refers to pain that persists after the expected healing period following an operation. It may relate to scar tissue, nerve irritation, altered mechanics, incomplete healing or other post-operative structural factors.

MBR Health provides advanced imaging on the Gold Coast for persistent pain after surgery, scar-related pain, post-operative nerve symptoms and unresolved structural pain patterns.

Scar tethering refers to scar tissue that restricts normal tissue glide or movement. This can create pain, tightness or traction-like symptoms during movement or stretching.

Yes. Ongoing pain after surgery doesn’t always mean the procedure didn’t work. In some cases, a nerve can become irritated due to scar tissue, changes in the area, or how the body has healed — even when the main goal of surgery was achieved.

NerveView MRI is a specialised scan that helps identify nerve irritation or inflammation that may not show up on standard imaging, especially after surgery where the anatomy has changed.

Imaging may be helpful if pain continues beyond the expected healing time, comes back after improving, limits your movement, involves nerve symptoms like tingling or numbness, or if previous scans haven’t provided clear answers.

The focus is on identifying the cause of persistent pain. If imaging identifies a treatable issue, you may then explore image-guided treatment options through our Regenerative & Targeted Therapies pathways.

Yes. Whole-body MRI is available in Australia through selected imaging providers. However, not all Whole-body MRI scans are the same – and unfortunately some fail the technical capability to meet international guidelines. The quality of a whole body MRI scan can vary significantly depending on the MRI platform (3T vs 1.5T), field strength, protocol design, diffusion imaging technique, distortion correction, anatomical coverage, acquisition time and radiologist experience in whole body MRI interpretation. At MBR Health, our exclusive Whole Body MRI™ protocol was built for oncology and is now offered for screening. Unlike other providers offering “body-surveys” not for clinical use, our full-body scan exceeds international standards for sensitivity and accuracy because of our high-fidelity, distortion free full-body imaging, and experienced whole body MRI reporting radiologist. This scan is designed for individuals who seek a medically directed approach to early detection and proactive health assessment.

MBR Health provides Australia’s most advanced oncology-grade Whole Body MRI™ screening on the Gold Coast in Queensland, with patients travelling from Brisbane, regional Queensland, interstate and overseas for our exclusive imaging capabilities. Our Whole Body MRI™ pathway uses oncology-focused 3T MRI protocols, DWIBS diffusion imaging, distortion correction and experienced whole body MRI radiologist reporting to support early detection of suspicious cancer-related and clinically important findings.

Whole Body MRI™ screening is available at MBR Health on the Gold Coast, Queensland. MBR Health combines 3T MRI, high-fidelity whole-body protocols, diffusion-weighted imaging and specialist radiologist interpretation within a medically directed screening pathway. This makes the service suitable for patients seeking Whole-body MRI cancer screening, proactive health assessment or a more advanced alternative to routine imaging alone.

Whole-body MRI is used to assess multiple organ systems in a single examination. It may help identify suspicious cancer-related findings, marrow abnormalities, soft tissue lesions, organ lesions and other clinically important structural changes that may require further investigation or specialist review. Whole-body MRI may also detect selected non-cancerous findings, such as aneurysms, inflammatory conditions, fatty liver disease, pancreatic cystic lesions, spine abnormalities or joint disease.

Whole-body MRI cancer screening is an imaging examination designed to assess the body for suspicious lesions or structural abnormalities that may suggest cancer or require further investigation. Unlike diagnostic imaging, which is guided by symptoms, screening is performed in asymptomatic individuals to detect conditions in their infancy, before symptoms arise. who are asymptomatic to detection conditions in their infancy, before they become clinically apparent. In most cases, earlier detection broadens treatment options and improves health outcomes. Whole-body MRI is particularly well suited to screening because it does not use ionising radiation, unlike CT or PET/CT. This makes it particularly attractive for selected patients seeking proactive cancer screening, longitudinal surveillance, or a radiation-free imaging option.

No. Whole Body MRI does not use ionising radiation. This is one of the major differences between Whole Body MRI and imaging tests such as CT or PET/CT. Instead of X-rays, MRI uses magnetic fields and radiofrequency pulses to generate images. However, some targeted screening pathways may still require CT or other imaging depending on the clinical question. For example, lung cancer screening may require low-dose or spectral CT in selected patients. For more information, read our Whole Body MRI resource article “Why Whole Body MRI includes Low-Dose CT Chest”

The best Whole-body MRI is not defined by the scan name alone. Important factors include: 3T MRI capability High-quality diffusion imaging DWIBS whole-body imaging Distortion correction Protocol depth Anatomical coverage Acquisition time Targeted complementary imaging Specialist radiologist interpretation Clear follow-up recommendations A brief or low-detail scan may provide reassurance, but not necessarily diagnostic confidence. At MBR Health, Whole Body MRI™ is designed around imaging fidelity, clinical relevance and careful interpretation.

The terms Whole-body MRI and Full-body MRI are often used interchangeably — and for most patients, they refer to the same thing: an MRI scan that assesses the whole-body rather than a single organ or region. In medical imaging, Whole-body MRI is the more precise term. It refers to a structured protocol designed to assess multiple organ systems in a single examination — rather than a general survey of the body without clinical intent. The distinction matters because not every full-body MRI is built to the same standard. A scan described as a “full-body MRI” may vary significantly in protocol design, anatomical coverage, diffusion technique and clinical rigour. At MBR Health, the service is referred to as Whole Body MRI™ because it reflects a medically directed, protocol-driven examination, not a generic body survey.

Whole-body MRI and regular MRI are used for different purposes. A regular MRI usually focuses on one body region, such as the brain, spine, knee, prostate or breast. It provides detailed regional imaging. Whole-body MRI is designed to assess multiple organ systems in one examination. It provides broader structural visibility, but may still need to be complemented by targeted imaging when a specific organ requires greater detail. The best pathway is often not whole-body imaging alone, but the correct combination of Whole-body MRI and targeted imaging based on risk, symptoms and clinical history.

No. Whole -body MRI does not replace every established cancer screening test. Depending on your age, sex, symptoms, risk factors and family history, you may still require colonoscopy, breast imaging, cervical screening, prostate assessment, skin checks, blood tests or specialist review. Whole-body MRI is best understood as an additional layer of structural visibility, not a universal replacement for all cancer screening.

No imaging test can detect all cancers. Whole-body MRI can help identify many suspicious lesions and clinically important abnormalities, but some cancers may be too small, biologically subtle, located in areas better assessed by another test, or not well demonstrated on MRI. The aim is to identify the earliest stage of disease with the most confidence – not perform the fastest cheapest scan. That is why MBR Health combines Whole Body MRI™ with targeted organ imaging where appropriate. The aim is not false reassurance. The aim is earlier visibility, better clinical selection and clearer next steps.

Depending on the protocol and clinical context, Whole-body MRI may help identify suspicious findings involving organs and tissues such as the brain, liver, kidneys, pancreas, gallbladder, stomach, oesophagus, bones, connective tissues, lymph nodes and bone marrow. It may be useful in assessing suspicious findings related to solid tumours, sarcoma, lymphoma, multiple myeloma and metastatic disease. However, the effectiveness of Whole Body MRI depends heavily on protocol quality, diffusion imaging, anatomical coverage and radiologist interpretation.

DWIBS stands for diffusion-weighted imaging with background body signal suppression. It is an MRI technique used in Whole-body MRI to help highlight areas where water movement is restricted within tissues. Restricted diffusion can be seen in many cancers, inflammatory processes and other clinically important abnormalities. It is the single most important sequence for early cancer detection in a whole body MRI screening scan. DWIBS is a key part of high-quality Whole-body MRI cancer screening because it adds functional information beyond anatomy alone.

A 3T MRI scanner has a stronger magnetic field than a 1.5T MRI scanner. In many settings, 3T MRI can provide higher signal and improved image quality, which can be useful for high-resolution imaging and whole-body protocols. However, scanner strength alone is not enough. The quality of Whole-body MRI also depends on protocol design, diffusion imaging, distortion correction, acquisition time and specialist interpretation. At MBR Health, Whole Body MRI™ is performed using oncology-focused 3T MRI protocols designed for diagnostic fidelity.

Oncology-grade Whole-body MRI refers to a whole-body imaging protocol designed with cancer detection, staging, surveillance or oncologic assessment in mind. It is not simply a quick whole-body scan. It requires attention to diffusion imaging, anatomical coverage, image quality, technical correction, organ-specific limitations and specialist radiologist review. At MBR Health, oncology-grade Whole Body MRI™ means the scan is built around the clinical question: detecting suspicious findings early and guiding appropriate next steps.

The time required for Whole Body MRI varies depending on the protocol, scanner, clinical purpose and whether targeted sequences are added. In general, higher-fidelity Whole Body MRI protocols may take longer than simplified screening scans because they acquire more detailed information. At MBR Health, acquisition time is treated as part of diagnostic quality. A faster scan is not a better scan if it sacrifices resolution, coverage or diffusion quality.

Often, longer acquisition time allows more detailed imaging, better anatomical coverage and more complete protocol design. However, time alone does not guarantee quality. A high-quality Whole Body MRI also requires the right sequences, technical correction, appropriate field of view, specialist protocol design and expert radiologist interpretation. The key question is not simply how long the scan takes, but whether the protocol is capable of answering the clinical question properly.

Whole Body MRI screening may be considered by patients seeking a proactive assessment of cancer risk or structural health, particularly when they want broader visibility than routine tests alone can provide. It may be relevant for patients with a family history of cancer, prior cancer history, elevated concern about early detection, complex symptoms, previous indeterminate findings or a desire for medically directed preventive screening. Suitability should always be assessed in context. Whole Body MRI is not appropriate for every patient or every clinical question.

Whole Body MRI may be suitable for selected asymptomatic patients who want proactive screening or early detection imaging. Many serious conditions can develop before symptoms appear. However, screening should still be medically considered, because imaging may detect incidental findings, require follow-up testing or identify abnormalities that need specialist review. At MBR Health, Whole Body MRI™ screening is selected according to risk profile, medical history, family history and patient goals.

Yes. Whole Body MRI may be used in selected cancer surveillance pathways, particularly where radiation-free imaging is desirable or where whole-body assessment of soft tissue, marrow or multi-organ disease is clinically relevant. However, surveillance imaging should be guided by the treating specialist, cancer type, prior treatment, tumour biology and clinical question. Whole Body MRI does not replace the role of the oncologist, surgeon or treating physician.

Whole Body MRI and PET/CT provide different types of information. PET/CT assesses metabolic activity and is valuable in many cancer staging and surveillance pathways. Whole Body MRI provides high-resolution structural and diffusion-based imaging without ionising radiation. One is not universally better than the other. The right test depends on the cancer type, clinical question, prior imaging, treatment history and specialist recommendation. At MBR Health, imaging selection is based on clinical suitability, not a one-size-fits-all approach.

Whole Body MRI and CT are different tools. MRI has the advantage of avoiding ionising radiation and can provide excellent soft-tissue, marrow and diffusion-based information. CT can be superior for lung assessment, calcification, bone detail and some acute or staging questions. For cancer screening, the best pathway may include Whole Body MRI plus targeted CT, spectral CT or organ-specific imaging where appropriate.

Whole Body MRI may show some lung or chest-related abnormalities, but CT is generally more sensitive for small pulmonary nodules and early lung cancer screening. For patients with smoking history, occupational exposure, respiratory symptoms or elevated lung cancer risk, low-dose CT or spectral CT may be more appropriate depending on clinical context. This is why MBR Health uses targeted screening rather than relying on Whole Body MRI alone for every organ system.

Whole Body MRI is not a replacement for dedicated breast imaging. Breast cancer screening or assessment may require mammography, breast ultrasound or dedicated breast MRI depending on age, breast density, symptoms, family history and risk profile. At MBR Health, Whole Body MRI may be complemented by targeted breast imaging where greater breast-specific sensitivity and anatomical detail are required.

Although very good for screening, Whole Body MRI is not a substitute for dedicated prostate MRI when prostate cancer assessment is required. A dedicated prostate MRI uses specific sequences and a targeted pelvic protocol designed to evaluate the prostate in more detail. For men with elevated PSA, family history, symptoms or prostate cancer concern, Whole Body MRI may need to be complemented by dedicated prostate imaging and specialist review.

The cost of Whole Body MRI in Australia varies depending on the provider, protocol, scan duration, technology, reporting model and whether targeted additional imaging is included. Patients comparing Whole Body MRI pricing should also compare what is included: scanner strength, DWIBS imaging, acquisition time, anatomical coverage, radiologist expertise, follow-up recommendations and whether the scan is part of a medically directed pathway. For current pricing at MBR Health, patients should contact the clinic directly.

Whole Body MRI screening is not covered by Medicare when performed as a preventive screening examination without a specific Medicare-eligible indication. Some targeted MRI examinations may be eligible for Medicare rebates in defined clinical circumstances, but this depends on the indication, referral, item number and eligibility criteria. Patients should confirm costs, rebates and eligibility with the clinic before booking.

Referral requirements may vary depending on the imaging provider, the type of scan and the clinical pathway. At MBR Health, patients can enquire about Whole Body MRI™ screening and the team can advise what referral or consultation pathway is appropriate based on the clinical context. A medically directed approach is important because the value of screening depends on selecting the right imaging for the right patient.

If Whole Body MRI identifies a suspicious or clinically important finding, the next step may include targeted imaging, comparison with prior scans, blood tests, specialist referral, biopsy or follow-up surveillance. At MBR Health, findings are interpreted by specialist radiologists and communicated with recommendations for appropriate next steps. The goal is not simply to detect abnormalities. The goal is to determine which findings matter and what should happen next.

MBR Health offers the most advanced Whole Body MRI™ screening pathway in Australia. The model is designed around diagnostic quality, clinical context and specialist interpretation. Located on the Gold Coast in Queensland, MBR Health combines 3T MRI, DWIBS diffusion imaging, high-fidelity whole-body protocols, targeted organ imaging where appropriate and radiologist-led clinical oversight. For patients searching for the best Whole Body MRI in Australia, the key difference is not just access to a scanner. It is the standard of the protocol, the interpretation and the pathway that follows.

Whole Body MRI may be worthwhile for selected patients seeking proactive cancer screening, radiation-free imaging or broader structural visibility than routine tests alone. Its value depends on the patient’s risk profile, medical history, scan quality, protocol depth and how findings are interpreted and followed up.

There is no single best full body scan for every patient. Whole Body MRI is valuable because it avoids ionising radiation and can assess multiple organ systems, soft tissues and marrow. However, CT, PET/CT, mammography, colonoscopy, prostate MRI, skin checks or blood tests may be more appropriate for specific cancers or risk profiles. The best cancer screening pathway is selected according to the clinical question.

A cheaper or shorter Whole Body MRI may use a simplified protocol with less anatomical detail, shorter acquisition time or limited diffusion imaging. A high-fidelity Whole Body MRI is built around image quality, diffusion technique, anatomical coverage, distortion correction, protocol depth and specialist interpretation. For cancer screening, these differences matter because the goal is not simply to complete a scan. The goal is to detect clinically important findings early and accurately – poor quality scans may offer nothing more than false confidence (and a lighter wallet).

Yes. Patients from Brisbane and South East Queensland can access Whole Body MRI™ screening at MBR Health on the Gold Coast. The clinic provides an advanced imaging-led pathway for patients seeking Whole Body MRI Queensland, Whole Body MRI Brisbane access, full body MRI screening or proactive cancer screening.

No. “Body scan” is a broad, non-specific term that may refer to CT, MRI, ultrasound, DEXA or other imaging tests. Whole Body MRI refers specifically to an MRI-based examination designed to assess multiple body regions without ionising radiation. The quality and clinical usefulness of a Whole Body MRI depend heavily on the protocol, equipment and reporting expertise.

Yes. MBR Health offers the Executive Preventive Health Program for organisations looking to provide executive health screening for their leadership teams. The program uses precision, multi-modality whole-body imaging to screen for cancer, cardiac, metabolic, neurological and musculoskeletal conditions within a single, integrated pathway. Tailored group offerings are available for organisations. Please enquire directly to discuss your team’s requirements.

A cardiovascular assessment is a structured evaluation of heart and vascular risk. It may include clinical history, blood pressure, blood markers, coronary calcium scoring, CT coronary angiography, carotid Doppler ultrasound, brain vascular imaging or other tests depending on the patient’s risk profile and symptoms. The key is that each test answers a different question.

Cardiovascular disease is one of the leading causes of life years lost in Australia. A proper cardiovascular assessment will assist in minimising your risk of cardiac associated health issues.

MBR Health provides imaging-led cardiovascular assessment on the Gold Coast in Queensland. Assessment may include coronary calcium scoring, CT coronary angiography, carotid Doppler ultrasound, brain MRI, brain angiography and other targeted imaging depending on the clinical question.

A coronary calcium score is a low-dose CT scan that measures calcified plaque in the coronary arteries. It helps assess coronary atherosclerotic burden and may support cardiovascular risk stratification in selected patients. A calcium score is useful, but it does not show all plaque types and does not fully assess plaque vulnerability.

Coronary calcium scoring is available through selected radiology providers in Queensland. At MBR Health on the Gold Coast, coronary calcium scoring is performed using Spectral CT which provides calcified plaque detection alongside additional tissue information that a conventional CT calcium score cannot offer. Your score can be used as part of a broader cardiovascular assessment pathway, rather than interpreted as an isolated number.

Referral requirement depends on the type of cardiovascular assessment, the Medicare rebate eligibility and the provider. For selected cardiovascular screening tests such as coronary calcium score, a referral from a GP or specialist is recommended but not required. A referral is required for other cardiovascular health checks such as CT coronary angiography, MRI angiography and US carotid Doppler, as some of these are diagnostic imaging tests requiring IV contrast.. Contact our team to determine the most appropriate cardiovascular imaging pathway for your clinical context and goals.

CT coronary angiography, also called CTCA, is a CT scan using intravenous contrast (IV) to visualise the coronary arteries. Unlike a coronary calcium test, a CTCA is a diagnostic test that can assess coronary narrowing, plaque distribution and plaque type, including calcified and non-calcified plaque. CTCA is usually selected according to symptoms, a positive calcium score, individual risk profile, or specialist recommendation.

A coronary calcium score detects calcified plaque in the coronary arteries. It is a screening test rather than a diagnostic test — one that helps stratify cardiovascular risk and guide preventive planning. It can confirm that calcified atherosclerosis is present and quantify its burden, but it does not assess non-calcified plaque, coronary narrowing or plaque vulnerability. CT coronary angiography provides a more detailed assessment of the coronary arteries, including the vessel lumen, plaque morphology, coronary narrowing and both calcified and non-calcified plaque. It moves assessment from whether calcium exists to what kind of coronary disease may be present — and how significant it is. They are not interchangeable. They answer different questions. A calcium score may be the right starting point for risk stratification. CTCA may be appropriate when greater anatomical detail, plaque characterisation or coronary narrowing assessment is required.

Yes. A calcium score of zero means no calcified plaque was detected, but it does not completely exclude non-calcified plaque, particularly in younger patients or earlier phases of coronary artery disease. This is why calcium scoring should be interpreted in clinical context rather than treated as a complete clearance test.

CT coronary angiography is not a default screening test for every asymptomatic person. It requires intravenous contrast, involves radiation and should be selected according to clinical context, symptoms, risk profile and expected benefit. For some patients, CTCA may provide important additional information. For others, a calcium score or other assessment may be more proportionate.

Yes. A stress test assesses whether blood flow is limited under stress. It does not necessarily show whether plaque is present in the coronary artery wall. A normal stress test can be genuinely reassuring for flow-limiting obstruction at the time of testing. However, many cardiovascular events arise from plaque that is non-obstructive, silent and functionally invisible under stress — until it destabilises. This is why structural imaging, such as coronary calcium scoring or CT coronary angiography, can provide important additional information in selected patients, particularly those with risk factors, family history or a strong personal interest in earlier cardiovascular assessment.

VO₂ max is a measure of cardiorespiratory fitness and physiological capacity. It is useful, but it is not a direct measure of coronary artery plaque or arterial wall disease. Importantly, high fitness can coexist with coronary plaque. A person can have an excellent VO₂ max, perform at a high level and still carry significant non-obstructive atherosclerotic burden that would not be detected by fitness testing alone. Coronary calcium scoring or CT coronary angiography, where appropriate, can provide assessment of the coronary arteries that fitness metrics cannot.

Carotid Doppler ultrasound is a non-invasive ultrasound examination that assesses blood flow through the carotid arteries in the neck. It can detect plaque, narrowing and altered flow patterns that may relate to stroke risk or broader vascular disease.

Brain MRI can show structural changes that may relate to vascular health, including previous silent infarcts, white matter disease and other brain findings. Brain angiography can assess selected blood vessels for narrowing, aneurysm or other vascular abnormalities. It does not replace a full cardiovascular assessment, but it can provide important information in selected patients.

There is no single best heart screening test for every patient. The best test depends on the question being asked. Blood markers estimate probability. Calcium scoring assesses calcified plaque burden. CT coronary angiography assesses coronary anatomy and plaque type. Stress testing assesses flow limitation. Echocardiography and cardiac MRI assess cardiac structure and function. A good cardiovascular assessment selects the right test for the right question.

Cardiovascular imaging may be considered for patients with a family history of early heart disease or stroke, high cholesterol, elevated lipoprotein(a), high blood pressure, diabetes, metabolic risk, smoking history, symptoms, abnormal prior testing or a desire for proactive prevention. Suitability depends on clinical assessment.

No assessment can guarantee prevention of a heart attack or stroke. The purpose of cardiovascular assessment is to identify risk, detect relevant disease where possible and guide earlier preventive action. The value lies in selecting the right test for the right patient and using the result to inform appropriate medical management.

Yes. MBR Health offers the Executive Preventive Health Program for organisations looking to provide executive health screening for their leadership teams. The program uses precision, multi-modality whole-body imaging to screen for cancer, cardiac, metabolic, neurological and musculoskeletal conditions within a single, integrated pathway. Tailored group offerings are available for organisations. Please enquire directly to discuss your team’s requirements.

A brain health assessment is a structured evaluation of brain structure, vascular health and cognitive risk. At MBR Health, this may include 3T brain MRI, volumetric brain analysis, quantitative neuroimaging, brain angiography and specialist radiologist interpretation depending on the clinical question.

MBR Health provides imaging-led brain health assessment on the Gold Coast in Queensland. Assessment may include high-resolution 3T brain MRI, volumetric MRI analysis, brain vascular imaging and quantitative neuroimaging for patients seeking cognitive longevity, dementia risk assessment or neurological evaluation.

Volumetric brain MRI uses quantitative analysis to measure selected brain structures. This may include hippocampal volume, cortical grey matter, ventricular size and regional asymmetry. These measurements can help establish a baseline and monitor change over time.

Brain MRI can identify structural patterns that may be associated with dementia, including regional atrophy, vascular injury, white matter disease or other abnormalities. However, brain MRI does not diagnose every cause of dementia by itself. Diagnosis usually requires clinical assessment, cognitive testing and, in selected cases, molecular imaging or biomarker testing.

Brain MRI can show patterns that may support Alzheimer’s disease assessment, such as medial temporal or hippocampal atrophy. However, MRI cannot confirm Alzheimer’s disease by itself. Amyloid PET, tau PET, blood biomarkers, CSF testing and specialist neurological assessment may be required depending on the clinical situation.

NeuroQuant® is an FDA-cleared MRI post-processing tool that provides automated volumetric measurements of selected brain structures. It can help quantify brain volumes and support longitudinal monitoring, but it must be interpreted by clinicians in the context of symptoms, history and other findings.

SyMRI is a quantitative MRI platform that can generate measurements of tissue characteristics such as grey matter, white matter, cerebrospinal fluid and myelin-related parameters. In selected cases, these measurements may support assessment of demyelination, tissue integrity and neurological disease patterns.

Yes. Brain MRI does not use ionising radiation. MRI uses magnetic fields and radiofrequency pulses to generate images, making it different from CT. Some MRI examinations may use contrast depending on the clinical question, but many brain health and screening protocols can be performed without contrast.

Brain MRI can show previous silent infarcts, white matter disease and other structural changes relevant to vascular brain health. Brain angiography can assess selected blood vessels for aneurysm, narrowing or vascular malformation. This does not replace a full cardiovascular assessment, but it can provide important information in selected patients.

White matter disease refers to changes in the brain’s white matter, often related to small vessel disease, ageing, vascular risk factors, inflammation or other neurological conditions. The clinical significance depends on the extent, pattern, patient age, symptoms and risk factors.

No. A normal brain MRI can be reassuring, but it does not exclude every early neurodegenerative, molecular or functional process. Brain health is often best assessed through clinical context, imaging, cognitive testing, biomarkers where appropriate and longitudinal monitoring.

Some brain volume change can occur with ageing. The key question is whether the pattern, degree or rate of change is greater than expected for age and clinical context. Volumetric brain MRI can help provide objective measurements for comparison and follow-up.

Brain health imaging may be considered for patients with memory concerns, family history of dementia, vascular risk factors, neurological symptoms, prior abnormal imaging or proactive cognitive longevity goals. Suitability depends on clinical assessment and the question being asked.

No. Brain MRI and cognitive testing answer different questions. MRI assesses structure, volume and selected vascular or tissue findings. Cognitive testing assesses performance, memory, executive function and processing speed. Both may be useful depending on the clinical context.

The best brain scan for memory loss depends on the clinical question. A high-resolution brain MRI can assess structural change, vascular injury, atrophy, mass lesions and white matter disease. Volumetric analysis may add objective measurement of selected brain structures. In selected cases, PET imaging or biomarker testing may be required.

There is no universal interval for brain health monitoring. Follow-up depends on age, symptoms, risk factors, prior imaging findings, family history and the reason for assessment. In some patients, a baseline MRI may be enough. In others, longitudinal follow-up may be useful to assess change over time.

Yes. MBR Health offers the Executive Preventive Health Program for organisations looking to provide executive health screening for their leadership teams. The program uses precision, multi-modality whole-body imaging to screen for cancer, cardiac, metabolic, neurological and musculoskeletal conditions within a single, integrated pathway. Tailored group offerings are available for organisations. Please enquire directly to discuss your team’s requirements.

Lung health screening is an imaging-led assessment designed to look for early lung abnormalities before symptoms become advanced. It may include low-dose CT, ultra-low-dose CT or low-dose Spectral CT depending on the patient’s risk profile and clinical question.

MBR Health provides lung health screening and low-dose CT lung assessment on the Gold Coast in Queensland. Depending on clinical suitability, assessment may include low-dose Spectral CT, ultra-low-dose CT, pulmonary nodule assessment and specialist radiologist interpretation.

Low-dose CT lung screening uses a CT scan with reduced radiation exposure to assess the lungs for nodules and other abnormalities. The Australian National Lung Cancer Screening Program uses low-dose CT scans to look for lung cancer in high-risk people without symptoms. The approximate effective radiation dose for a low-dose spectral chest CT (more information than a normal low-dose chest CT) is <1 mSv and ultra-low dose chest CT <0.2 mSv.

Eligibility for Australia’s National Lung Cancer Screening Program includes being aged between 50 and 70, having no signs or symptoms suggesting lung cancer, currently smoking or having quit within the past 10 years, and having a tobacco smoking history of at least 30 pack-years.

MBR Health’s private lung health screening pathway is separate from the National Lung Cancer Screening Program. It may be considered for patients seeking specialist low-dose or spectral CT lung assessment, including those who may not meet public program eligibility or who require a more personalised imaging pathway. Patients who may meet National Lung Cancer Screening Program criteria should discuss eligibility with their GP or healthcare provider.

Spectral CT is an advanced CT technology that can provide additional information beyond conventional CT in selected settings. For lung imaging, it may support lesion assessment, tissue characterisation and more detailed interpretation where spectral information is clinically useful.

Low-dose CT is designed to reduce radiation exposure while maintaining diagnostic image quality for the clinical question. Ultra-low-dose CT reduces dose further and may be appropriate for selected screening or surveillance scenarios where the required information can still be obtained confidently. The best protocol depends on the patient, the clinical question and whether spectral data is needed.

All CT scans involve ionising radiation, so the decision to perform lung CT should be clinically justified. ARPANSA states that national diagnostic reference levels help ensure medical imaging doses are kept as low as reasonably achievable while avoiding unnecessary exposure. At MBR Health, dose is matched to the clinical question and interpreted in the context of expected benefit.

Radiation dose varies depending on patient size, scanner settings and protocol. MBR Health protocol examples include approximately 0.7 mSv for selected low-dose spectral lung CT and approximately 0.2 mSv for selected ultra-low-dose lung CT pathways. For comparison, ARPANSA states that average natural background radiation in Australia is approximately 1.7 mSv per year.

Low-dose CT can detect lung nodules and suspicious findings before symptoms appear. The Australian Government states that lung cancer screening helps detect cancer at an earlier stage, and that early diagnosis can lead to more treatment options and a better chance of cure.

Whole Body MRI may show some lung or chest-related abnormalities, but CT is generally more appropriate for small pulmonary nodules and lung-specific screening questions. At MBR Health, lung CT may be recommended as a targeted complement to Whole Body MRI™ when lung screening or pulmonary nodule assessment is clinically important.

A preventative lung CT may identify pulmonary nodules, early suspicious lung lesions, emphysema, airway disease, bronchiectasis, fibrosis, scarring, post-inflammatory change, occupational lung changes and other clinically relevant lung abnormalities. Findings may require comparison with previous imaging, interval surveillance, targeted diagnostic CT, respiratory referral or specialist review.

Referral requirements depend on whether the scan is being performed as private screening, diagnostic imaging or under a specific Medicare-eligible pathway. Patients should contact MBR Health to confirm referral requirements, pricing and clinical suitability.

Lung screening may be considered in selected non-smokers with relevant risk factors, such as occupational exposure, family history, persistent symptoms, previous inflammatory lung disease or other clinical concerns. However, the decision should be clinically guided. Not every low-risk patient requires lung CT screening.

No. Lung screening does not replace respiratory physician assessment when symptoms, abnormal findings or complex lung disease are present. Imaging helps identify and characterise structural findings. Further management may require GP review, respiratory referral, specialist follow-up or multidisciplinary care.

Yes. MBR Health offers the Executive Preventive Health Program for organisations looking to provide executive health screening for their leadership teams. The program uses precision, multi-modality whole-body imaging to screen for cancer, cardiac, metabolic, neurological and musculoskeletal conditions within a single, integrated pathway. Tailored group offerings are available for organisations. Please enquire directly to discuss your team’s requirements.

A metabolic and bone health assessment is a structured evaluation of body composition, bone density and liver health. At MBR Health, this may include DEXA body composition, DEXA bone density scanning, quantitative liver MRI and ultrasound elastography depending on the clinical question.

MBR Health provides DEXA scanning on the Gold Coast for body composition assessment, bone density testing and metabolic health tracking. DEXA can help measure lean mass, fat mass, visceral fat and bone density with more detail than weight or BMI alone.

A DEXA body composition scan uses dual-energy X-ray absorptiometry to measure fat mass, lean mass and bone mass. It can provide regional information, helping show where fat and muscle are distributed across the body.

DEXA body composition focuses on fat mass, lean mass, visceral fat and regional body composition. A bone density scan focuses on bone mineral density, osteopenia, osteoporosis and fracture risk. Both use DEXA technology, but they answer different clinical questions.

DEXA provides more detailed regional measurement of fat, lean mass and bone than most consumer smart scales or bioimpedance devices. Bioimpedance can be affected by hydration, timing, device quality and algorithm assumptions. DEXA is generally more precise for tracking body composition over time.

Yes. DEXA body composition can estimate visceral adipose tissue, which is fat stored around internal organs. Visceral fat is important because it is associated with insulin resistance, inflammation and cardiometabolic risk.

A bone density scan measures bone mineral density and helps assess osteopenia, osteoporosis and fracture risk. DXA is the preferred method for measuring bone mineral density because it has excellent precision, minimal radiation and is useful for predicting fracture and monitoring treatment.

A bone density scan may be considered for people with risk factors such as age over 70, menopause, family history of osteoporosis, prior low-trauma fracture, long-term steroid use, low body weight, smoking, certain medications or medical conditions affecting bone health. Your doctor can advise whether bone density testing and Medicare eligibility apply.

Medicare rebates for bone density scanning apply only in specific circumstances. Healthdirect notes that people aged over 70 years or people with certain medical conditions may be eligible for a Medicare rebate, and the MBS lists bone densitometry items for eligible patients aged 70 years and over. Body composition DEXA performed for private health tracking is generally not Medicare-rebated.

A referral is generally required if the scan is for bone density assessment and Medicare rebate eligibility. A referral may not be required for a private DEXA body composition scan, but patients should confirm booking requirements with MBR Health before attending.

No. DEXA uses a very low dose of ionising radiation. This dose is much lower than many other X-ray-based imaging tests, but it is still not radiation-free. MRI and ultrasound-based liver assessments do not use ionising radiation.

Quantitative liver MRI is an MRI-based assessment that can measure liver fat and liver iron. It does not use ionising radiation and may be useful for patients with suspected fatty liver disease, haemochromatosis risk, metabolic risk or abnormal liver blood tests.

Yes. MRI can quantify liver fat and may be used to assess hepatic steatosis, including fatty liver disease associated with metabolic dysfunction. This can provide additional information beyond routine blood tests in selected patients.

Ultrasound elastography, often known as FibroScan, measures liver stiffness. Liver stiffness can provide information about fibrosis or scarring risk in selected patients. It may be used alongside liver blood tests, liver MRI and clinical assessment.

Yes. Liver blood tests can be normal in some patients with fatty liver disease or early fibrosis. Imaging and elastography may provide additional structural and quantitative information when liver risk is suspected.

No. Metabolic imaging does not replace blood tests. Blood tests assess biochemical, hormonal and inflammatory markers. DEXA and quantitative imaging assess body composition, bone density, liver fat, liver iron and tissue characteristics. The best assessment often combines both.

This assessment may be considered for patients with metabolic risk, weight change, visceral fat concern, low muscle mass, osteoporosis risk, menopause, fatty liver disease, abnormal liver tests, haemochromatosis risk or preventative health goals. Suitability depends on the clinical question.

Yes. MBR Health offers the Executive Preventive Health Program for organisations looking to provide executive health screening for their leadership teams. The program uses precision, multi-modality whole-body imaging to screen for cancer, cardiac, metabolic, neurological and musculoskeletal conditions within a single, integrated pathway. Tailored group offerings are available for organisations. Please enquire directly to discuss your team’s requirements.

Yes. MRI is considered one of the safest imaging modalities because it uses no ionising radiation. The main safety considerations relate to implanted metal devices, which our safety team will carefully assess. Mild side effects from contrast, such as headache or nausea, are rare and usually short-lived.

Some MRI services in Australia attract Medicare rebates, but our advanced 3T MRI technology is not fully covered due to licensing restrictions. Scans at MBR are privately billed, allowing us to provide research-grade imaging with more sequences and higher resolution.

No. MBR Health offers privately funded, research-grade imaging designed to deliver diagnostic accuracy the first time, reducing the need for repeat scans and shortening wait times. To learn more about MRI and Medicare, read our Insight article: “MRI Medicare Rebates Explained“

Yes. A referral from a GP or specialist is required for all MRI scans. This ensures the study is clinically appropriate and tailored to your needs.

Most results are sent to your doctor within 2–3 business days, though some sub-specialty studies (such as breast or cardiac MRI) may take slightly longer. Urgent cases are prioritised, and patients can access reports and images via the secure MBR Patient Portal.

In selected cases, we offer bespoke applications such as functional MRI (fMRI) and other research protocols. These are available following an appropriate referral and consultation with our lead MRI technologist to ensure the protocol is tailored to your clinical or research requirements.

Spectral CT uses different energy levels to better differentiate tissues, improve contrast resolution and sometimes reduce the amount of iodine contrast needed. CT does involve ionising radiation, but our advanced scanner uses very low doses whenever possible. MRI uses magnetic fields and radio waves to produce highly detailed images of soft tissues, organs, joints and the nervous system. MRI does not use radiation and is particularly useful for detecting subtle abnormalities.

Iodine contrast is used in CT scans and is injected to highlight blood vessels, organs and tissues. Patients with iodine allergies or certain kidney conditions may need special precautions. Gadolinium is used in MRI scans to improve visibility of tissues, blood flow or inflammation. It is generally well-tolerated and considered very safe when used appropriately.

MRI scans generally range in time from 30 minutes to 2 hours. A standard muscle, tendon, ligament or joint (MSK) MRI will take approximately 30 minutes per region. The addition of NerveVIEW, dynamic MRI or other specialised imaging will require additional time.

Our exclusive Whole Body MRI imaging is typically 90 minutes to 100 minutes. You typically cannot reduce the time without compromising the image quality or diagnostic information.

Functional MRI (fMRI) uses specialised MRI sequences to assess how tissues behave, not just how they look. It may help evaluate brain activity, tissue cellularity, blood flow or other physiological features, depending on the clinical question. At MBR Health, functional MRI may be used when advanced insight is needed beyond standard anatomical imaging.

Dynamic MRI captures movement or change over time, rather than only producing still images. It may be useful when symptoms relate to motion, positioning or functional behaviour that is not fully explained on a standard scan. At MBR Health, dynamic MRI is used selectively to help clarify diagnosis and guide care.

In most cases the base CT scan performed on our spectral platform is covered by Medicare when referred by an eligible practitioner. Some advanced spectral applications such as additional reconstructions or quantitative analysis may incur an out-of-pocket fee. We will always confirm any costs before your appointment.

Many diagnostic spectral CT scans are bulk billed through Medicare. If your doctor requests specialised applications such as advanced oncology staging or detailed quantitative reporting, there may be an out-of-pocket fee. Our bookings team will explain this clearly at the time of scheduling.

Yes. A referral from your GP or specialist is required for all Spectral CT scans at MBR Health. This helps us tailor the protocol, contrast use and spectral reconstructions to your specific clinical needs.

MBR Health on the Gold Coast accepts imaging requests on any referral paper.

Fasting is only required if your scan includes intravenous contrast, in which case you will be asked to fast for a minimum of two hours prior to your appointment. Some studies require a longer fasting period and our team will advise you of your specific requirements when booking. If your scan does not require contrast, no special preparation is needed.

Spectral CT scans are relatively quick, typically taking between 5 and 10 minutes. Some studies require brief breath holds during the scan and our radiographers will guide you through these clearly as they occur.

In most cases your results will be available within 48 to 72 hours and will be sent directly to your referring doctor. Your report and images will also be accessible through the MBR Health patient portal within the same timeframe. For clinically urgent referrals we offer expedited reporting, often within one business day. Please let our team know if you require your results sooner and we will do our best to accommodate your request.

Spectral CT does everything conventional CT can do — and more. By providing material differentiation, advanced reconstructions and additional spectral information from a single acquisition, it can enhance the detection and characterisation of disease, including cancer and vascular pathology. The result is more comprehensive diagnostic information, with the potential to optimise radiation exposure and contrast use.

While all CT imaging involves ionising radiation, our Spectral CT technology and tailored protocols are designed to optimise dose while maintaining diagnostic quality. When contrast is required, our specialised protocols can also reduce the volume of contrast administered where clinically appropriate.

Dr Zane Sherif’s innovative injection protocols enable multiple diagnostic phases to be captured within a single acquisition, providing comprehensive diagnostic information while helping to minimise both radiation and contrast exposure.

Spectral CT uses multiple energy levels to better differentiate materials and tissues, enhance contrast resolution and, where clinically appropriate, optimise the amount of iodine contrast required.

CT uses ionising radiation; however, our advanced Spectral CT technology and tailored protocols are designed to achieve high-quality diagnostic images while keeping radiation exposure as low as reasonably achievable.

MRI uses magnetic fields and radio waves to produce highly detailed images of soft tissues, organs, joints and the nervous system. Unlike CT, MRI does not use ionising radiation and is particularly valuable for detecting subtle changes and abnormalities that may not be visible with other imaging techniques.

Iodine contrast is used in CT scans and is injected to highlight blood vessels, organs and tissues. Patients with iodine allergies or certain kidney conditions may need special precautions. Gadolinium is used in MRI scans to improve visibility of tissues, blood flow or inflammation. It is generally well-tolerated and considered very safe when used appropriately.

Most medically necessary ultrasound examinations referred by a GP or specialist attract a Medicare rebate. Some advanced or non-Medicare procedures may be privately billed. Our team will always clarify any out-of-pocket costs before your appointment.

We do not routinely bulk bill ultrasound examinations. A private fee applies depending on the type of examination. Any out-of-pocket costs will be clearly explained at the time of booking.

Ultrasound uses sound waves, not radiation, and has no known harmful effects. It is considered one of the safest imaging modalities available and is safe for use across all patient groups including children and pregnant patients. Internal ultrasound examinations may cause mild temporary discomfort but are considered very safe.

Yes. A referral from a GP or specialist is required for all ultrasound examinations at MBR Health. This ensures the correct examination is performed and results are communicated back to your clinician.

Contrast-enhanced ultrasound uses a small injection of microbubble contrast agent to improve visualisation of blood flow and tissue vascularity. It is particularly useful for tumour characterisation, liver lesion assessment and complex vascular studies, providing additional diagnostic information beyond standard ultrasound without ionising radiation.

Elastography is an advanced ultrasound technique that measures tissue stiffness, providing objective information about tissue health. It is commonly used to assess liver fibrosis, thyroid nodules and soft tissue lesions, helping clinicians make more informed diagnostic decisions without the need for invasive procedures.

Results are typically available to your referring doctor within 2 to 3 business days. Urgent studies can be prioritised and your report and images will be accessible through the MBR Health patient portal following review.

Yes. DEXA uses very low-dose X-ray technology — up to 80 times less radiation than conventional DEXA machines and significantly less than a standard chest X-ray. It is non-invasive, painless and suitable for repeated monitoring over time.

A referral from a GP or specialist is required for bone mineral density scanning to ensure the scan is clinically appropriate and to determine Medicare eligibility. No referral is required for a private body composition scan, though we also accept doctor referrals when body composition is part of a broader medical assessment.

Medicare rebates may apply for bone mineral density scanning for eligible patients. Eligible patients include those aged 70 years and over, individuals with established osteoporosis, certain hormonal or chronic conditions, long-term corticosteroid use or a history of minimal trauma fractures. Please speak with your GP to determine whether you meet the eligibility criteria. Body composition scanning is not covered by Medicare and is privately billed.

Bone mineral density scanning is not bulk billed at MBR Health. A Medicare rebate may apply for eligible patients, with an out-of-pocket fee payable. Body composition scanning is privately billed with no Medicare rebate applicable. Our team will confirm all costs clearly before your appointment.

For bone mineral density monitoring, frequency depends on your fracture risk profile. High-risk patients are typically scanned every one to two years, moderate-risk patients every three to five years and low-risk patients every ten to fifteen years. Your doctor will advise based on your individual circumstances. For body composition monitoring, a scan every three to four months is appropriate if you are actively working on weight management, muscle gain or metabolic health programs.

A whole-body body and/or bone mineral density scan takes less than 10 to 15 minutes. Both can be performed in the same appointment if required.

Body composition results are available on the day of your scan. Bone mineral density results are reviewed by a specialist radiologist and typically available within one to two business days, sent directly to your referring doctor. Your report and images will also be accessible through the MBR Health patient portal.

X-ray imaging is one of the most commonly used diagnostic tests for assessing bones, joints, the chest and certain soft-tissue conditions. It is often used to investigate fractures, arthritis, spinal alignment, chest symptoms, joint pain and injury.

In most cases, a referral from your GP, specialist, dentist, chiropractor, physiotherapist or other eligible healthcare provider is required for an X-ray examination. Your referral helps ensure the correct area is imaged and that the results are interpreted in the right clinical context.

Dental imaging may include OPG, lateral cephalogram and other dental X-ray examinations used to assess teeth, jaws, wisdom teeth, dental alignment, sinus-related dental concerns and pre-treatment planning. These examinations are commonly requested by dentists, orthodontists, oral surgeons and medical practitioners. High-quality dental imaging can support accurate diagnosis, treatment planning and monitoring over time.

X-ray and dental imaging use ionising radiation, but modern imaging systems are designed to keep radiation exposure as low as reasonably achievable while still producing diagnostic images. The clinical benefit of imaging is always considered against the small radiation exposure involved. Particular care is taken for children, pregnancy and repeat imaging, and patients are encouraged to let our team know if they may be pregnant before any X-ray examination.

MBR Health provides X-ray and dental imaging services for patients across the Gold Coast, including Mermaid Beach, Broadbeach, Burleigh, Robina, Miami, Varsity Lakes and surrounding areas. Our imaging services are designed to support timely diagnosis, clear reporting and coordinated care between patients, referrers and treating clinicians. Whether you require a general X-ray, dental X-ray, OPG or related imaging, our team can assist with booking and preparation.

Yes. A referral from your GP or specialist is required for all diagnostic procedures at MBR Health. This ensures the correct procedure is performed and results are communicated back to your clinician.

Most procedures are well-tolerated. Local anaesthetic is used to minimise discomfort at the procedure site. You may experience mild pressure or temporary discomfort during the procedure, but significant pain is uncommon. Please let our team know at any time if you are uncomfortable.

Most procedures take between 15 and 45 minutes depending on the type and complexity. Please allow additional time for preparation and a brief observation period after your procedure if required.

Tissue and fluid samples are sent to a pathology laboratory. Results are typically available within seven days, though turnaround time may vary depending on the laboratory and the complexity of the analysis. Results will be sent directly to your referring doctor and accessible through the MBR Health patient portal.

Medicare rebates apply to most diagnostic procedures when referred by an eligible practitioner. Out-of-pocket fees may apply depending on the procedure type. Our team will confirm all costs clearly before your appointment.

We do not routinely bulk bill diagnostic procedures. A Medicare rebate may apply for eligible patients with an out-of-pocket fee payable. Our bookings team will explain all costs clearly at the time of scheduling.

Yes. All procedures at MBR Health are performed under image guidance by our experienced clinical team. Image guidance ensures precise needle placement, minimising risk to surrounding structures. As with any procedure, there are small risks including minor bleeding, bruising or infection, which our team will discuss with you during the consent process before your procedure begins.

Most diagnostic procedures at MBR Health are performed under local anaesthetic alone and do not require sedation. Local anaesthetic is administered to the procedure site to minimise discomfort, and the majority of patients find procedures well-tolerated without the need for additional sedation. For patients who are particularly anxious, please speak with your referring doctor or GP prior to your appointment to discuss whether mild oral sedation such as diazepam (Valium) may be appropriate.

PRP stands for platelet-rich plasma. It is a treatment made from your own blood, processed to concentrate platelets and their associated signalling molecules, then delivered to a selected tissue target.

No. PRP can vary significantly depending on platelet dose, cellular composition, how it is prepared and how it is delivered. That is why two clinics may both say they offer PRP while delivering very different products.

PRP may be used in selected cases of osteoarthritis, tendinopathy, ligament injury, muscle injury and some nerve-related or spine-adjacent pain pathways where the diagnosis and tissue target support a biologic treatment rationale.

Cortisone is generally used to suppress inflammation and can provide faster short-term symptom relief. PRP is a biologic treatment intended to stimulate a healing response and is not designed as an immediate anaesthetic or steroid-like effect.

Platelet dose matters because platelets carry growth factors and other signalling molecules that influence the tissue response. A higher-quality PRP pathway aims to deliver a clinically meaningful platelet concentrate rather than a minimal or highly diluted preparation.

At MBR Health, PRP is image-guided where appropriate so the biologic is delivered to the tissue actually being treated rather than the general area of pain. Guidance may involve ultrasound, CT or another imaging strategy depending on the anatomy.

This depends on the system being used, the platelet dose required and the tissue being treated. Higher-dose PRP pathways usually require a larger blood draw than simplified tube-based systems.

Because PRP is made from your own blood, it avoids the issues associated with donor tissue or foreign biologics. However, procedural safety still depends on appropriate patient selection, sterile preparation, imaging guidance and medical governance.

PRP is not designed to work like a steroid injection. Some patients notice improvement within weeks, while others require longer depending on the tissue, chronicity and biological response.

Platelet-rich plasma therapy is not currently covered by Medicare in Australia. PRP is considered an emerging and investigational therapy for most indications and does not attract a Medicare rebate.

MBR Health’s PRP pathway is built around diagnosis, biologic quality and precision delivery. The aim is not simply to offer PRP, but to decide when it is appropriate, prepare it properly and deliver it to the right target.

Hyaluronic acid is a substance naturally found in the body that helps lubricate, cushion and protect joints. In osteoarthritis and some other conditions, that natural environment becomes less protective.

Durolane is an ultra-high molecular weight hyaluronic acid product used in selected treatment pathways at MBR Health. It is chosen for its long duration of action, safety profile and single-injection convenience.

No. Ultra-high molecular weight HA differs from lower-molecular-weight alternatives that may require more frequent injections and offer shorter duration of effect.

At MBR Health, hyaluronic acid may be considered in selected knee osteoarthritis, frozen shoulder and nerve sheath hydrodissection pathways, depending on diagnosis and treatment goals.

Yes. In selected cases — particularly knee osteoarthritis in active individuals — HA may be combined with PRP where a dual cushioning and tissue-support rationale exists.

Durolane is an ultra-high molecular weight hyaluronic acid which has been shown to last significantly longer than many lower- or medium-molecular-weight HA products, with symptom relief of up to 18 months after a single injection reported in selected knee osteoarthritis studies.

The supply of Durolane is not covered by Medicare, although some components of the image-guided procedure may be eligible for rebate depending on the pathway.

A referral is required from a GP or specialist. Diagnostic imaging is often needed before intervention.

MBR Health’s HA pathway is built around diagnosis, product selection and precision delivery. The aim is not simply to offer an HA injection, but to determine when it is appropriate, use the right product and deliver it to the right target.

Cortisone is used mainly to reduce inflammation. RFA uses heat near a targeted sensory nerve to reduce pain signalling. PRF uses brief electrical fields to modulate pain around a selected nerve without the same thermal effect.

Corticosteroid injections are commonly used for inflammatory pain in selected joints, bursae and soft-tissue structures, and can provide temporary relief for weeks to months.

Radiofrequency ablation is a procedure that uses heat delivered near a target nerve to interrupt pain signalling. It is commonly considered for selected chronic neck, back and arthritic joint pain pathways.

Pulsed radiofrequency uses short bursts of radiofrequency energy to influence pain signalling around a selected nerve while limiting thermal tissue injury compared with continuous thermal ablation.

No. RFA is generally a thermal lesioning treatment for selected sensory nerves. PRF is generally used as a neuromodulatory treatment and is designed to reduce pain signalling without the same destructive heat profile.

MBR Health provides image-guided pain management assessment on the Gold Coast for selected inflammatory, facet-mediated and nerve-related pain pathways.

This page focuses on pain management pathways such as cortisone, RFA and PRF. Where the anatomy and diagnosis support a regenerative approach instead, patients may also explore PRP, BMAC or hyaluronic acid through the Regenerative & Targeted Therapies section.

A whole-body MRI is a comprehensive, non-invasive scan used to determine whether cancer is present and, if so, whether it has spread throughout the body. Using advanced 3T MRI technology, it provides detailed images of the bones, bone marrow, lymph nodes and many internal organs, all without exposure to ionising radiation.

For certain cancers, whole-body MRI may be an alternative to PET/CT, particularly in younger individuals or when minimising radiation exposure is an important consideration. The most appropriate imaging test will depend on your cancer type and your treating doctor’s clinical assessment.

Yes. At MBR Health, our whole-body MRI examinations for oncology are recommended to include an intravenous (IV) gadolinium contrast injection. Contrast enhances the detail seen on MRI and provides additional information that helps our radiologist assess tumours more accurately.

When whole-body MRI is performed over time, contrast-enhanced imaging can also help evaluate changes in tumour behaviour and response to treatment, providing valuable information for your treating specialist.

Gadolinium contrast is different from the iodine-based contrast used for CT scans and is generally safe for most individuals. Before your examination, we will review your medical history, including any kidney disease, previous contrast reactions or pregnancy, to ensure it is appropriate for you.

Yes. A referral from your treating specialist or doctor is required. This ensures the examination is appropriate for your clinical situation and allows us to tailor the MRI protocol to your diagnosis and the specific questions your healthcare team needs answered.

Whole-body MRI is one of MBR Health’s areas of expertise. Our examinations are performed on advanced 3T MRI scanners using proprietary imaging protocols that have been developed and refined to maximise image quality and diagnostic confidence.

Our team has pioneered innovations in diffusion-weighted whole-body MRI, including in-line geometric distortion correction (DWIBS), enabling high-resolution imaging with improved anatomical accuracy. This provides our radiologists with high-fidelity images to support accurate cancer staging and assessment of treatment response.

Every examination is performed by experienced MRI radiographers and interpreted by specialist radiologists with expertise in whole-body MRI. We work closely with referring specialists to deliver comprehensive reports that support informed clinical decision-making.

We also prioritise patient comfort. Our MRI suites feature an in-bore audiovisual system that allows patients to watch entertainment during their examination, helping make longer scans a more comfortable experience.

For some cancers, yes. Whole-body MRI may be used as an alternative to PET/CT for cancer staging and treatment monitoring, particularly when avoiding exposure to ionising radiation is an important consideration.

Whole-body MRI provides excellent assessment of the bones, bone marrow, lymph nodes and many soft tissues, while PET/CT measures metabolic activity and can be more suitable in certain clinical situations.

The most appropriate imaging test depends on your cancer type, clinical history and the information your treating doctor needs. In some cases, whole-body MRI and PET/CT provide complementary information and may both be recommended.

Whole-body Spectral CT is an advanced CT examination that provides detailed anatomical images of your whole-body while also capturing additional information about tissue composition, This allows radiologists to better characterise abnormalities than is possible with conventional CT alone.

Yes. Most whole-body Spectral CT examinations are performed with an intravenous iodinated contrast injection. Contrast helps improve visualisation of blood vessels, organs and tumours and is essential for obtaining the full diagnostic benefits of Spectral CT.

MBR Health combines state-of-the-art Spectral CT technology with experienced radiographers and specialist radiologists to deliver high-quality imaging for cancer diagnosis, staging and treatment monitoring. Our advanced imaging protocols are designed to maximise diagnostic information and support informed clinical decision-making.

Potentially. Spectral CT is an emerging technology that provides more information than conventional CT by measuring the characteristics of tissues, rather than simply their size and shape.

Researchers are investigating whether quantitative measurements from Spectral CT can identify changes in tumours earlier during treatment, helping doctors assess whether a therapy is working before changes in tumour size become apparent.

One exciting area of research is immunotherapy, where Spectral CT may help distinguish between pseudoprogression, a temporary increase in tumour size caused by an immune response, and true disease progression. If validated in future studies, this could help clinicians make treatment decisions in real-time and reduce the need to wait for repeat confirmation scans.

While these applications continue to evolve, Spectral CT is at the forefront of precision imaging and is expected to play an increasingly important role in personalised cancer care.

Non-compression Spectral CT breast imaging is an emerging imaging technique that allows the breasts to be examined without the compression required for conventional mammography.

Using advanced Spectral CT technology and intravenous contrast, the examination provides detailed anatomical and functional information about breast tissue. Researchers are investigating its role in improving the detection and characterisation of breast cancers by evaluating tumour blood supply and other imaging biomarkers.

Prostate MRI is one of the most accurate imaging tests available for detecting clinically significant prostate cancer. It can identify suspicious areas within the prostate and help determine whether a biopsy is needed. However, no imaging test is perfect, and some cancers may not be visible on MRI.

Mammography remains the primary test for breast cancer screening and has been shown to reduce deaths from breast cancer through early detection. However, like all imaging tests, it has limitations. Some findings may be indeterminate and require additional imaging or short-term follow-up, particularly in women with dense breast tissue.

Breast MRI is one of the most sensitive imaging techniques for detecting breast cancer and provides detailed information about breast tissue that cannot be seen on mammography alone. It is commonly recommended for women at high risk of breast cancer, to assess the extent of a newly diagnosed cancer, monitor response to treatment, or investigate findings that remain inconclusive on mammography or ultrasound.

No. The quality and diagnostic value of a breast MRI depend on the MRI scanner, imaging protocol, radiographer expertise and the experience of the reporting radiologist.

Breast MRI is one of the most technically demanding MRI examinations. The breasts are located adjacent to the lungs and heart, so normal breathing and cardiac motion can introduce image artefacts that reduce image quality. Obtaining consistently sharp, high-resolution images requires advanced imaging techniques, careful patient positioning and experienced MRI radiographers. For this reason, choosing an experienced provider is important.

MRI and colonoscopy have different roles and are complementary rather than competing tests.

Colonoscopy is the gold standard for diagnosing rectal cancer because it allows direct visualisation of the bowel lining and enables biopsies to confirm the diagnosis. However, it only assesses the inner surface of the rectum and, due to the camera’s field of view and the need to navigate the bowel lumen, some lesions, particularly those that are flat, subtle, or partially obscured, may be difficult to fully visualise. It also cannot determine how far a tumour has spread beyond the bowel wall.

High-resolution rectal MRI provides detailed assessment of the rectal wall, surrounding tissues and lymph nodes, making it the preferred examination for staging rectal cancer and planning treatment.